Wei-Qi Wei

Study finds a role for AI in drug repurposing pipeline

Vanderbilt researchers are using artificial intelligence to search for existing drugs used for other problems that might help patients Alzheimer’s Disease.

PheWAS reveals post-COVID-19 diagnoses

Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.

(iStock)

New method enhances efforts to identify drug repurposing targets

Researchers at Vanderbilt University Medical Center have developed a new method for identifying drugs for the repurposing trials that can lead to new indications for drugs already in use.

Grant creates center for maternal, pediatric precision therapeutics

Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics.

Drug allergy labels in medical records power searches for gene-drug associations

Team analyzed clinical notes to identify COVID symptoms

At the start of the COVID-19 pandemic, public health authorities first had to identify and draw attention to common signs and symptoms of the disease.